Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | 1 | 203A21A | IM / LA |
PATIENT REPORTED EXPERIENCING TINNITUS 6-8 WEEKS AFTER INJECTION. HE HAD A FOLLOW UP WITH AN AUDIOLOGIST AND IT WAS CONFIRMED ON 01/2022. PATIENT STATED HE NEVER HAD TINNITUS PRIOR.
UNKNOWN
UNKNOWN
UNKNOWN
UNKNOWN
AUDIOLOGIST IN 01/2022